Safety of autologous stem cell transplantation in patients with known Human T‐cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients

1. Tefferi A, Guglielmelli P, Larson DR, et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood. 2014;124(16):2507-2513. quiz 2615. 2. Kourie HR, Ameye L, Paesmans M, Bron D. Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysis. Br J Haematol. 2017;179(20):846-848. 3. Lau WW, Hannah R, Green AR, Gottgens B. The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients. Blood. 2015;125(10):1679-1681. 4. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-2405. 5. Bartels S, Lehmann U, Busche G, et al. SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation. Leukemia. 2015;29(1):253-255. 6. Tefferi A, Lasho TL, Finke CM, et al. CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia. 2014;28(7):1472-1477.

[1]  Y. Yamano,et al.  Risk of Human T-Cell Leukemia Virus Type 1 Infection in Kidney Transplantation. , 2019, The New England journal of medicine.

[2]  J. Sloan,et al.  Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home. , 2017, Hematology/oncology clinics of North America.

[3]  A. Krishnan,et al.  Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. , 2016, Blood.

[4]  M. Seto,et al.  Detection of an early adult T-cell leukemia-lymphoma clone in lymph nodes with anaplastic lymphoma kinase-negative anaplastic large cell lymphoma involvement. , 2016, Cancer genetics.

[5]  A. Gessain,et al.  Epidemiological Aspects and World Distribution of HTLV-1 Infection , 2012, Front. Microbio..

[6]  K. Yamaguchi,et al.  Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. , 2010, Blood.

[7]  M. Matsuoka,et al.  Donor-derived T-cell leukemia after bone marrow transplantation. , 2006, The New England journal of medicine.

[8]  K. Ohshima,et al.  Prognosis of HTLV-I-positive renal transplant recipients. , 2005, Transplantation proceedings.

[9]  R. Mahieux,et al.  HTLV-1 and associated adult T-cell leukemia/lymphoma. , 2003, Reviews in clinical and experimental hematology.

[10]  J. D. van der Walt,et al.  Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  G. Gahrton,et al.  Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV‐I) following allogeneic bone marrow transplantation for HTLV‐I positive adult T‐cell leukaemia , 1994, British journal of haematology.

[12]  W. Williams,et al.  Adult T-cell leukemia/lymphoma in a renal transplant recipient: an opportunistic occurrence. , 1994, American journal of nephrology.

[13]  S. Asano,et al.  Adult T‐cell leukemia developing during immunosuppressive treatment in a renal transplant recipient , 1992, American journal of hematology.